Risk-reducing salpingo-oophorectomy is associated with a 96% reduction in the risk of tubo-ovarian cancer; and may be associated with a reduction in breast cancer risk in the carriers of BRCA2, but not BRCA1, variants [98,99]. Here, BRCA2 is linked to breast cancer.